These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38788029)

  • 41. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
    Xia Q; Dong S; Bian PD; Wang J; Li CJ
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levothyroxine Treatment Adequacy and Formulation Changes in Patients with Hypothyroidism: A Retrospective Study of Real-World Data from the United States.
    Bianco AC; Bao Y; Antunez Flores O; Halpern R; Le L; Stackland S; Frieze T
    Thyroid; 2023 Aug; 33(8):940-949. PubMed ID: 37335236
    [No Abstract]   [Full Text] [Related]  

  • 43. The pattern of thyroid function of subclinical hypothyroid women with levothyroxine treatment during pregnancy.
    Yu X; Chen Y; Shan Z; Teng W; Li C; Zhou W; Gao B; Shang T; Zhou J; Ding B; Ma Y; Wu Y; Liu Q; Xu H; Liu W; Li J; Wang W; Li Y; Fan C; Wang H; Zhang H; Guo R
    Endocrine; 2013 Dec; 44(3):710-5. PubMed ID: 23508303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association Between Generic-to-Generic Levothyroxine Switching and Thyrotropin Levels Among US Adults.
    Brito JP; Deng Y; Ross JS; Choi NH; Graham DJ; Qiang Y; Rantou E; Wang Z; Zhao L; Shah ND; Lipska KJ
    JAMA Intern Med; 2022 Apr; 182(4):418-425. PubMed ID: 35226058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression].
    Kowalczyk P; Roskosz J; Jurecka-Tuleja B; Gubała E; Czernik E; Jarzab B
    Wiad Lek; 2001; 54(5-6):268-76. PubMed ID: 11556209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
    Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
    Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liothyronine Improves Biochemical Control of Congenital Hypothyroidism in Patients with Central Resistance to Thyroid Hormone.
    Paone L; Fleisch AF; Feldman HA; Brown RS; Wassner AJ
    J Pediatr; 2016 Aug; 175():167-172.e1. PubMed ID: 27178621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of thyroid hormone supplementation after thyroid lobectomy.
    Lee DY; Seok J; Jeong WJ; Ahn SH
    J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levothyroxine treatment for congenital hypothyroidism based on thyroid function: a 10-year clinical retrospective study.
    He S; Ma X; Yang J; Li L
    BMC Endocr Disord; 2022 May; 22(1):142. PubMed ID: 35643448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [No Abstract]   [Full Text] [Related]  

  • 53. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
    Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M
    Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels.
    Kim H; Jung J; Cho YS; Choi JY; Park H; Lee YB; Kim SW; Chung JH; Kim TH
    Sci Rep; 2021 Nov; 11(1):22322. PubMed ID: 34785735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TSH evaluation in hypothyroid patients assuming liquid levothyroxine at breakfast or 30 min before breakfast.
    Pirola I; Gandossi E; Brancato D; Marini F; Cristiano A; Delbarba A; Agosti B; Castellano M; Cappelli C
    J Endocrinol Invest; 2018 Nov; 41(11):1301-1306. PubMed ID: 29582344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with Radioiodine.
    Matrone A; Faranda A; Latrofa F; Gambale C; Stefani Donati D; Molinaro E; Agate L; Viola D; Piaggi P; Torregrossa L; Basolo F; Elisei R
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32453405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study.
    Papaleontiou M; Chen DW; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Haymart MR
    Thyroid; 2021 Sep; 31(9):1383-1390. PubMed ID: 33779292
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
    Appetecchia M
    Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current recommendations for levothyroxine treatment of differentiated thyroid cancer patients are not properly implemented in clinical practice.
    Martins de Almeida JF; Gonçalves Tsumura W; Vaisman M; Montalli Assumpção LV; Ward LS
    J Endocrinol Invest; 2012 Nov; 35(10):901-4. PubMed ID: 22522710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The thyroid axis 'setpoints' are significantly altered after long-term suppressive LT4 therapy.
    Verburg FA; Mäder U; Grelle I; Visser TJ; Peeters RP; Smit JW; Reiners C
    Horm Metab Res; 2014 Oct; 46(11):794-9. PubMed ID: 24867137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.